1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Xoft, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab Radiation: Intra-operative Radiation Therapy - IORT, Bevacizumab - Glioblastoma, Recurrent Glioblastoma | Phase 2 | Terminated | Xoft, Inc. | 12 | 2021-11-02 | 2024-04-26 |
Glioblastoma (1)
Bevacizumab (1)
United States (1)